Call Us: +44 (0) 1752 753723info@biovaultfamily.com
umbilical-cord-blood-improve-outcomes-children-autism

Cord blood stem cell trial finds improvements in autism symptoms

Parents of 25 children with autism spectrum disorder (ASD) report that their children showed reduced signs of ASD after a recent stem cell treatment. The children received infusions of their own stem cells from banked umbilical cord blood as part of a clinical trial. ASD-related behaviour reduction The children (aged between two and five years)...

diabetes cord blood

UF Health diabetes researchers discover a way to expand potent regulatory cells

For parents, storing their newborn baby’s umbilical cord blood is a way to preserve potentially lifesaving cells. Now, a group of University of Florida Health researchers has found a way to expand and preserve certain cord-blood cells as a potential treatment for Type 1 diabetes. The findings involve thymic...

Osteoarthritis - Cord blood treatment

Cellular-Based Treatment for Knee Osteoarthritis

Osteoarthritis is a degenerative disease of the joints for which pain management is the most common treatment. Researchers are investigating using bone marrow aspirate concentrate (BMAC) as a cellular-based method of regenerating damaged tissue and treating osteoarthritis. Patients with osteoarthritis (OA) suffer from painful inflammation in their joints and...

Degenerative disc disease - cord blood treatment

Stem Cell Therapies for Degenerative Disc Disease

Mesenchymal stem cell (MSC) therapy, also known as regenerative medicine therapy, is emerging as a promising treatment for degenerative disc disease (DDD). Wenchun Qu, MD, PhD, from Mayo Clinic in Rochester, Minnesota, reviewed the pathophysiology of DDD and advances in MSC preparation techniques at the American Academy of Pain...

Alzheimer's disease - cord blood treatment

Longeveron Achieves Milestone in Groundbreaking Stem Cell Trial for Alzheimer’s Disease

Longeveron, a leading stem cell research company focused on biological solutions for age-associated diseases, announced today the successful completion of enrollment in the first phase of its clinical research trial of Longeveron allogeneic human mesenchymal stem cells (LMSCs®) to treat Alzheimer’s disease. The fifth and final patient needed for...

Diabetes type 1 - cord blood treatments

Stem cell transplant findings could lead to personalised type 1 diabetes treatments

A clinical trial has shown promising findings from stem cell transplants in people with type 1 diabetes, with some patients coming off insulin injections for several years. This international research could also lead to better outcomes for more patients who undergo stem cell transplantation, according to senior author Dr...

Multiple sclerosis: Stem cell transplantation may halt disease progression

New research provides further evidence of autologous hematopoietic stem cell transplantation as an effective treatment for multiple sclerosis, after finding the procedure halted disease progression for 5 years in almost half of patients.   Lead study author Dr. Paolo Muraro, of the Department of Medicine at Imperial College London...

Early Results Show Irregular Heartbeat Improves After Mesenchymal Stem Cells Treatment

A new study published this month in STEM CELLS Translational Medicine indicates that treating heart patients with mesenchymal stem cells (MSCs) does not increase their risk of irregular heart beat (arrhythmia). In fact, the MSCs had the opposite effect and showed promise of improving the condition.   “This could...

Caroline Wyatt: MS ‘brain fog’ lifted after stem cell treatment

BBC journalist Caroline Wyatt has spoken of how the “brain fog began to lift” after she had pioneering treatment for multiple sclerosis (MS).   The former BBC defence correspondent was deemed unsuitable for an NHS trial and paid $60,000 (£48,000) for a stem cell transplant in Mexico in January....

Stem cell transplants may induce long-term remission of multiple sclerosis

New clinical trial results provide evidence that high-dose immunosuppressive therapy followed by transplantation of a person’s own blood-forming stem cells can induce sustained remission of relapsing-remitting multiple sclerosis (MS), an autoimmune disease in which the immune system attacks the central nervous system.   Five years after receiving the treatment,...